Contrary Games is thrilled to announce that Pathos will arrive on PC via Steam on 4 November, with a demo coming out in a few ...
In a single news cycle, Pathos AI announced two simultaneous drug licensing agreements worth up to $2.3 billion in combined milestones — and disclosed that it is targeting a $300 million Series E ...
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE)-- Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today announced the acquisition of a majority stake in ...
Pathos AI to license experimental breast cancer drug from China's Jiangsu Alphamab Biopharmaceutical
Aug 4 (Reuters) - New York City-based Pathos AI will pay $125 million upfront to a subsidiary of Alphamab Oncology (9966.HK), opens new tab for rights to an experimental drug for a type of breast ...
Iker Huerga, Pathos AI's chief executive. Pathos AI has added to its pipeline of cancer drugs by licensing a bispecific antibody-drug conjugate (ADC) for solid tumours from China's Alphamab in a deal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results